A detailed history of Rhumbline Advisers transactions in Accuray Inc stock. As of the latest transaction made, Rhumbline Advisers holds 97,427 shares of ARAY stock, worth $189,982. This represents 0.0% of its overall portfolio holdings.

Number of Shares
97,427
Previous 106,092 8.17%
Holding current value
$189,982
Previous $193,000 9.33%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$1.41 - $2.49 $12,217 - $21,575
-8,665 Reduced 8.17%
97,427 $175,000
Q2 2024

Aug 01, 2024

BUY
$1.49 - $2.43 $3,306 - $5,392
2,219 Added 2.14%
106,092 $193,000
Q1 2024

May 09, 2024

SELL
$2.37 - $2.94 $5,714 - $7,088
-2,411 Reduced 2.27%
103,873 $256,000
Q4 2023

Feb 08, 2024

SELL
$2.44 - $3.08 $8,252 - $10,416
-3,382 Reduced 3.08%
106,284 $300,000
Q3 2023

Nov 09, 2023

BUY
$2.63 - $4.26 $16,792 - $27,200
6,385 Added 6.18%
109,666 $298,000
Q2 2023

Aug 08, 2023

BUY
$2.7 - $3.97 $247,976 - $364,616
91,843 Added 802.96%
103,281 $399,000
Q2 2022

Aug 11, 2022

SELL
$1.76 - $3.52 $154,126 - $308,253
-87,572 Reduced 88.45%
11,438 $22,000
Q1 2022

May 12, 2022

BUY
$3.16 - $4.81 $1,674 - $2,549
530 Added 0.54%
99,010 $328,000
Q4 2021

Feb 10, 2022

SELL
$3.72 - $5.88 $5,632 - $8,902
-1,514 Reduced 1.51%
98,480 $470,000
Q3 2021

Nov 12, 2021

BUY
$3.5 - $4.56 $5,327 - $6,940
1,522 Added 1.55%
99,994 $395,000
Q2 2021

Aug 05, 2021

SELL
$4.24 - $5.51 $30,277 - $39,346
-7,141 Reduced 6.76%
98,472 $445,000
Q1 2021

May 06, 2021

SELL
$4.25 - $5.89 $23,162 - $32,100
-5,450 Reduced 4.91%
105,613 $523,000
Q4 2020

Feb 10, 2021

BUY
$2.53 - $4.71 $18,646 - $34,712
7,370 Added 7.11%
111,063 $463,000
Q3 2020

Nov 12, 2020

SELL
$1.98 - $2.74 $30,501 - $42,209
-15,405 Reduced 12.93%
103,693 $249,000
Q2 2020

Aug 13, 2020

BUY
$1.7 - $2.56 $7,541 - $11,356
4,436 Added 3.87%
119,098 $242,000
Q4 2019

Feb 05, 2020

BUY
$2.56 - $3.08 $1,195 - $1,438
467 Added 0.41%
114,662 $323,000
Q3 2019

Oct 23, 2019

SELL
$2.58 - $4.14 $1,935 - $3,104
-750 Reduced 0.65%
114,195 $316,000
Q2 2019

Aug 14, 2019

BUY
$3.54 - $4.64 $12,577 - $16,485
3,553 Added 3.19%
114,945 $445,000
Q1 2019

May 01, 2019

BUY
$3.32 - $5.28 $992 - $1,578
299 Added 0.27%
111,392 $531,000
Q4 2018

Jan 31, 2019

BUY
$3.31 - $5.24 $120,920 - $191,427
36,532 Added 49.0%
111,093 $379,000
Q3 2018

Nov 07, 2018

SELL
$3.48 - $4.6 $18,879 - $24,954
-5,425 Reduced 6.78%
74,561 $336,000
Q2 2018

Aug 06, 2018

BUY
$3.85 - $5.15 $17,017 - $22,763
4,420 Added 5.85%
79,986 $328,000
Q1 2018

May 02, 2018

SELL
$4.5 - $5.9 $11,475 - $15,045
-2,550 Reduced 3.26%
75,566 $378,000
Q4 2017

Feb 09, 2018

SELL
$3.95 - $5.3 $51,610 - $69,249
-13,066 Reduced 14.33%
78,116 $336,000
Q3 2017

Nov 06, 2017

BUY
$3.9 - $4.6 $355,609 - $419,437
91,182
91,182 $365,000

Others Institutions Holding ARAY

About ACCURAY INC


  • Ticker ARAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 93,579,696
  • Market Cap $182M
  • Description
  • Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation the...
More about ARAY
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.